Latest Updates & News
Risk Factors for Chronic Low Back Pain: What You Should Know
What did the research discover? This study found that nearly one-third (32%) of patients with acute low back pain (LBP) transitioned to chronic LBP within six months. The risk of developing chronic pain was significantly associated with: Higher scores on the Subgroups for Targeted Treatment Back Tool (SBT), which predicts persistent functional limitations. Exposure...
Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis
What Did the Research Discover? Primary biliary cholangitis (PBC) is a rare liver disease that gradually damages the bile ducts, leading to liver scarring. If left untreated, it can progress to cirrhosis and severe liver disease. The current first-line treatment, ursodeoxycholic acid (UDCA), does not work for up to 40% of patients, and the second-line option,...
FDA News Update: Nationwide Shift to Natural Food Dyes Begins
For Immediate Release: April 22, 2025 The U.S. Department of Health and Human Services and U.S. Food and Drug Administration (FDA) today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant milestone in the administration’s broader initiative to Make America Healthy Again. The FDA is taking...
Revolutionary Eye Drops May Offer Future Non-Surgical Treatment for Cataracts
What Did the Research Discover? Cataracts are a leading cause of vision loss worldwide, affecting millions of people. As people age, the risk of developing cataracts increases, and while surgery is effective, it is expensive and not always available in all areas. Because of this, researchers are looking for medications that could help prevent or treat cataracts...
New Medications for Postpartum Depression: Safer Options for Older Mothers
What Did the Research Discover? Postpartum depression (PPD) is a serious mood disorder that affects many new parents after childbirth. It can cause extreme sadness, hopelessness, and difficulty caring for the baby. Current treatments, such as antidepressants, can take weeks to work and may have side effects. In August 2023, the FDA approved zuranolone, the first...
Magnetic Seizure Therapy: A Promising Treatment for Major Depression
What did the research discover? Researchers studied two different treatments for major depressive disorder (MDD): Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT). They wanted to see which one worked better for treating depression and which had fewer effects on memory and thinking skills. The study gathered data from 10 different studies, including...